ACE is involved in the catalytic hydrolysis of angiotensin I to Angiotensin II, a bioactive octapeptide that facilitates vasoconstriction and a key player in pathophysiology and progression of diabetic micro and macrovascular complications, including DCM [3, 55, 56]. The gene discussed is ACE; the disease is familial dilated cardiomyopathy.